Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children

被引:4
|
作者
Freeman, G. [1 ]
Ng, S. [2 ]
Perera, R. A. P. M. [3 ,4 ]
Fang, V. J. [1 ]
Ip, D. K. M. [1 ]
Leung, G. M. [5 ]
Peiris, J. S. M. [3 ,4 ]
Cowling, B. J. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China
[2] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA
[3] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Publ Hlth Lab Sci, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Li Ka Shing Fac Med, Div Community Med & Publ Hlth Practice, Hong Kong, Hong Kong, Peoples R China
来源
EPIDEMIOLOGY AND INFECTION | 2015年 / 143卷 / 03期
关键词
Immunization (vaccination); influenza; serology; statistics; PROTECTIVE EFFICACY; PANDEMIC INFLUENZA; ANTIBODY-RESPONSE; IMMUNE-RESPONSES;
D O I
10.1017/S0950268814000855
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We examined factors affecting the immunogenicity of trivalent inactivated influenza vaccination (TIV) in children using the antibody titres of children participating in a Hong Kong community-based study. Antibody titres of strains included in the 2009-2010 northern hemisphere TIV [seasonal A(H1N1), seasonal A(H3N2) and B (Victoria lineage)] and those not included in the TIV [2009 pandemic A(H1N1) and B (Yamagata lineage)] were measured by haemagglutination inhibition immediately before and 1 month after vaccination. Multivariate regression models were fitted in a Bayesian framework to characterize the distribution of changes in antibody titres following vaccination. Statistically significant rises in geometric mean antibody titres were observed against all strains, with a wide variety of standard deviations and correlations in rises observed, with the influenza type B antibodies showing more variability than the type A antibodies. The dynamics of antibody titres after vaccination can be used in more complex models of antibody dynamics in populations.
引用
收藏
页码:540 / 549
页数:10
相关论文
共 50 条
  • [21] Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
    Samson, Sandrine I.
    Leventhal, Phillip S.
    Salamand, Camille
    Meng, Ya
    Seet, Bruce T.
    Landolfi, Victoria
    Greenberg, David
    Hollingsworth, Rosalind
    EXPERT REVIEW OF VACCINES, 2019, 18 (03) : 295 - 308
  • [22] MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
    Patel, Sanjay S.
    Bizjajeva, Svetlana
    Heijnen, Esther
    Oberye, Janine
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 85 : S18 - S25
  • [23] STUDY OF THE IMMUNOGENICITY OF TRIVALENT INACTIVATED WHOLE-VIRION INFLUENZA VACCINE IN HUMAN VOLUNTEERS
    MOFFAT, MAJ
    PENNINGTON, TH
    ROBERTSON, AM
    VANVOORTHUIZEN, WF
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1982, 10 (02): : 83 - 90
  • [24] Immunogenicity and safety of influenza trivalent inactivated vaccine in hemodialysis patients and renal transplant recipients
    Scharpe, Johan
    Evenepoel, Pieter
    Claes, Kathleen
    Kuypers, Dirk
    Osterhaus, Albert D.
    Vanwalleghem, Johan
    Vanrenterghem, Yves
    Peetermans, Willy E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 228 - 228
  • [25] Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults
    Langley, JM
    Halperin, SA
    McNeil, S
    Smith, B
    Jones, T
    Burt, D
    Mallett, CP
    Lowell, GH
    Fries, L
    VACCINE, 2006, 24 (10) : 1601 - 1608
  • [26] Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil
    Capao, Artur
    Aguiar-Oliveira, Maria L.
    Caetano, Braulia C.
    Neves, Thayssa K.
    Resende, Paola C.
    Almeida, Walquiria A. F.
    Miranda, Milene D.
    Martins-Filho, Olindo A. ssis
    Brown, David
    Siqueira, Marilda M.
    Garcia, Cristiana C.
    VIRUSES-BASEL, 2022, 14 (08):
  • [27] Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children
    Hambidge, Simon J.
    Ross, Colleen
    Glanz, Jason
    McClure, David
    Daley, Matthew F.
    Xu, Stan
    Shoup, Jo Ann
    Narwaney, Komal
    Baggs, James
    Weintraub, Eric
    PEDIATRICS, 2012, 129 (01) : E54 - E59
  • [28] Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age
    DiazGranados, Carlos A.
    Saway, William
    Gouaux, James
    Baron, Mira
    Baker, Jeffrey
    Denis, Martine
    Jordanov, Emilia
    Landolfi, Victoria
    Yau, Eddy
    VACCINE, 2015, 33 (51) : 7188 - 7193
  • [29] Factors Affecting Sensitivity to Frequency Change in School-Age Children and Adults
    Buss, Emily
    Taylor, Crystal N.
    Leibold, Lori J.
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2014, 57 (05): : 1972 - 1982
  • [30] The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons
    Katayose, Masahiko
    Hosoya, Mitsuaki
    Haneda, Takashi
    Yamaguchi, Hideo
    Kawasaki, Yukihiko
    Sato, Masatoki
    Wright, Peter F.
    VACCINE, 2011, 29 (09) : 1844 - 1849